Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 211
Filter
1.
Ter Arkh ; 94(6): 738-742, 2022 Aug 04.
Article in Russian | MEDLINE | ID: mdl-36286850

ABSTRACT

BACKGROUND: Nephrotic syndrome (NS) is accompanied by a risk of thrombotic complications due to hypercoagulability. Routine laboratory tests are not sensitive enough to detect these disorders, and therefore the use of integral coagulation tests, including a new thrombodynamic test (TT) in patients with NS, is of high relevance. AIM: Using a TT to determine hemostasis disorders in patients with chronic glomerulonephritis (CGN) with NS. MATERIALS AND METHODS: The study included 49 patients with CGN, mean age 37 years, of which 25 (51%) women and 24 (49%) men. Of all the examined patients, 20 (40.8%) of people had NS, 29 (59.2%) had no NS. The process of clot formation was assessed by TT. RESULTS: According to TT, 30% (6/20) of patients with NS and 13.7% (4/29) of patients without NS have hypercoagulation with changes in parameters that go beyond the reference values. In patients with NS, an increase in clot density (D), clot formation rate (V) and clot size (CS) was found, especially when albumin decreased below 25 g/l. Negative correlations were found between the levels of albumin, creatinine and clot density (D), which reflects the level of hyperfibrinogenemia, the rate of clot formation (V) and the integral index of coagulation (CS). The results indicate mainly the activation of the plasma hemostasis due to the internal coagulation pathway. However, the correlation of Tlag (delay time for the onset of clot formation after contact of blood plasma with the insert-activator) with serum cholesterol levels may also indicate activation of the extrinsic coagulation pathway. CONCLUSION: In CGN patients with NS, activation of the plasma hemostasis is noted, as evidenced by an increase in the rate of formation (V) and size of the clot (CS) after 30 minutes, as well as the density of the formed clot (D).


Subject(s)
Glomerulonephritis , Nephrotic Syndrome , Thrombophilia , Thrombosis , Male , Humans , Female , Adult , Nephrotic Syndrome/complications , Nephrotic Syndrome/diagnosis , Creatinine , Hemostasis , Thrombophilia/complications , Thrombosis/etiology , Glomerulonephritis/complications , Glomerulonephritis/diagnosis , Chronic Disease , Albumins , Cholesterol
2.
Ned Tijdschr Geneeskd ; 1642020 06 11.
Article in Dutch | MEDLINE | ID: mdl-32613787

ABSTRACT

The Electronic Control Device (ECD) will be used by the primary police force in the Netherlands. Hence medical personnel will be confronted with persons that have received ECD shocks more often. In light of these developments, it is important that care providers are aware of potential medical consequences resulting from the use of electric stun guns. The darts usually result in minor injury with small penetration wounds requiring minimal treatment. However, in vulnerable areas, such as the eyes, the darts can cause serious injury and specialist care is indicated. The electric shock causes muscle contractions, potentially resulting in traumatic falls, or fractures. Cardiac problems occur only in exceptional cases; risk factors include long duration of the power surge, short distance from the darts to the heart and underlying heart problems. In rare cases a pneumothorax may occur. Finally, often there are underlying medical problems requiring appropriate treatment such as drug intoxication, excited delirium or psychiatric disorders. Systematic recording of the medical problems caused by anECD is indicated.


Subject(s)
Conducted Energy Weapon Injuries , Law Enforcement/methods , Weapons , Conducted Energy Weapon Injuries/epidemiology , Conducted Energy Weapon Injuries/therapy , Forensic Medicine/methods , Humans , Netherlands/epidemiology , Risk Assessment
3.
J Environ Qual ; 46(1): 210-218, 2017 Jan.
Article in English | MEDLINE | ID: mdl-28177415

ABSTRACT

Current understanding of the variability in soil properties and their relationship to processes and spatial patterns in forested landscapes is limited due to the scarcity of datasets providing such information. Here we present a spatially highly resolved dataset () that provides detailed information on the three-dimensional variability of biogeochemical properties in the Wüstebach catchment (western Germany), a long-term environmental observation site of the TERENO (Terrestrial Environmental Observatories) project. High-resolution soil sampling was conducted, and physical and biogeochemical soil parameters were recorded per horizon. The dataset is helpful in the analysis of the spatial heterogeneity in biogeochemical properties within soil horizons and with depth through the soil profile. In addition, it shows links between hydrological and biogeochemical properties and processes within the system. Overall, the dataset provides a high-resolution view into (re)cycling, leaching, and storage of nutrients on the catchment scale in a forested headwater catchment.


Subject(s)
Datasets as Topic , Forests , Soil/chemistry , Water Pollutants/chemistry , Environmental Monitoring , Germany , Water Pollutants/analysis
4.
Mol Oncol ; 10(5): 645-51, 2016 05.
Article in English | MEDLINE | ID: mdl-26797050

ABSTRACT

Comprehensive Cancer Centres (CCCs) serve as critical drivers for improving cancer survival. In Europe, we have developed an Excellence Designation System (EDS) consisting of criteria to assess "excellence" of CCCs in translational research (bench to bedside and back), with the expectation that many European CCCs will aspire to this status.


Subject(s)
Cancer Care Facilities , Neoplasms/therapy , Quality of Health Care , Translational Research, Biomedical , Cancer Care Facilities/standards , Europe , Humans , Quality of Health Care/standards , Translational Research, Biomedical/methods , Translational Research, Biomedical/standards
5.
Forensic Sci Int ; 257: 320-328, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26461030

ABSTRACT

The formation of adipocere slows further decomposition and preserves corpses for decades or even centuries. This resistance to degradation is a serious problem, especially with regard to the reuse of graves after regular resting times. We present results from an exhumation series in modern graveyards where coffins from water-saturated earth graves contained adipocere embedded in black humic material after resting times of about 30 years. Based on the assumption that this humic material resulted from in situ degradation of adipocere, its presence contradicts the commonly held opinion that adipocere decomposition only occurs under aerobic conditions. To test our hypothesis, we collected black humic material, adipocere as well as soil samples above and below coffins from representative graves (n=7). A comprehensive chemical analysis of the samples substantiated our in situ degradation theory. Element compositions and fatty acid mass spectra confirmed that the humic black material originated from the corpses. A van Krevelen diagram classified the excavated adipocere material as lipid, whereas the black humic material was closer to the carbohydrate region. Mass fragmentograms of the humic material revealed the presence of large amounts of saturated vs. unsaturated nC16 and nC18 fatty acids, which is typical for adipocere. In addition, the soil samples exhibited a lipid signature deriving primarily from plant waxes and root components (C20C32). Solid-state (13)C NMR spectra of adipocere displayed well-resolved signals of saturated aliphatic chains and a signal that corresponded to carboxylic acid groups. The NMR spectra of the black humic material revealed signals characteristic of long aliphatic chains. The intensities varied in relation to the state of degradation of the sample, as did the signals of oxidized aliphatic chains, acetals and ketals, aromatic structures, esters and amids. The analyses confirmed that the black humic material was indeed derived from adipocere, so the assumption is that the components detected must have developed from aliphatic fatty acids via a number of oxidation and condensation processes. We therefore propose the existence of chemical pathway(s) for the degradation of adipocere under poikiloaerobic conditions. Possible (biogeo)chemical reaction chains include (1) the autoxidation of fatty acids enhanced by haemoglobin, methaemoglobin and haemin, (2) the use of alternative electron acceptors, which leads to the formation of H2S that then reacts abiotically with iron (from haemoglobin), rendering iron sulphide, and (3) the Maillard reaction. These findings are another step forward in understanding the chemistry of buried corpses.


Subject(s)
Burial , Postmortem Changes , Soil/chemistry , Carbohydrates/analysis , Cemeteries , Exhumation , Fatty Acids/analysis , Humans , Lipids/analysis , Magnetic Resonance Spectroscopy
6.
Oncogene ; 33(5): 665-70, 2014 Jan 30.
Article in English | MEDLINE | ID: mdl-23318432

ABSTRACT

A gene signature specific for intestinal stem cells (ISCs) has recently been shown to predict relapse in colorectal cancer (CRC) but the tumorigenic role of individual signature genes remains poorly defined. A prominent ISC-signature gene is the cancer stem cell marker CD44, which encodes various splice variants comprising a diverse repertoire of adhesion and signaling molecules. Using Lgr5 as ISC marker, we have fluorescence-activated cell sorting-purified ISCs to define their CD44 repertoire. ISCs display a specific set of CD44 variant isoforms (CD44v), but remarkably lack the CD44 standard (CD44s) isoform. These CD44v also stand-out in transformed human ISCs isolated from microadenomas of familial adenomatous polyposis patients. By employing knock-in mice expressing either CD44v4-10 or CD44s, we demonstrate that the CD44v isoform, but not CD44s, promotes adenoma initiation in Apc(Min/+)mice. Our data identify CD44v as component of the ISCs program critical for tumor initiation, and as potential treatment target in CRC.


Subject(s)
Adenomatous Polyposis Coli/genetics , Cell Transformation, Neoplastic/genetics , Hyaluronan Receptors/genetics , Hyaluronan Receptors/metabolism , Intestinal Neoplasms/metabolism , Animals , Flow Cytometry , Gene Expression Profiling , Gene Knock-In Techniques , Mice , Mice, Transgenic , Neoplastic Stem Cells/cytology , Protein Isoforms/genetics , Protein Isoforms/metabolism , Receptors, G-Protein-Coupled/genetics , Tumor Cells, Cultured , Wnt Signaling Pathway/genetics
7.
Oncogene ; 29(1): 93-104, 2010 Jan 07.
Article in English | MEDLINE | ID: mdl-19802005

ABSTRACT

Wnt-signal transduction is critical for development and tissue homeostasis in a wide range of animal species and is frequently deregulated in human cancers. Members of the Frat/GBP family of glycogen synthase kinase 3beta (Gsk3b)-binding oncoproteins are recognized as potent activators of the Wnt/beta-catenin pathway in vertebrates. Here, we reveal a novel, Gsk3b-independent function of Frat converging on the activation of JNK and AP-1. Both these have been used as readouts for the noncanonical Frizzled/PCP pathway, which controls polarized cell movements and the establishment of tissue polarity. We find that Frat synergizes with Diversin, the mammalian homolog of the Drosophila PCP protein diego, in the activation of JNK/AP-1 signaling. Importantly, Frat mutants deficient for binding to Gsk3b retain oncogenic activity in vivo, suggesting that Wnt/beta-catenin-independent events contribute to Frat-induced malignant transformation. The observed activities of Frat are reminiscent of the dual function of Dishevelled in the Wnt/beta-catenin and Frizzled/PCP pathways and suggest that Frat may also function to bridge canonical and noncanonical Wnt pathways.


Subject(s)
Carrier Proteins/metabolism , Neoplasm Proteins/metabolism , Signal Transduction , Wnt Proteins/metabolism , Adaptor Proteins, Signal Transducing/genetics , Adaptor Proteins, Signal Transducing/metabolism , Animals , Blotting, Western , Carrier Proteins/genetics , Cell Line , Cytoskeletal Proteins/genetics , Cytoskeletal Proteins/metabolism , Dishevelled Proteins , Drosophila Proteins , Female , Glycogen Synthase Kinase 3/genetics , Glycogen Synthase Kinase 3/metabolism , Glycogen Synthase Kinase 3 beta , Humans , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , JNK Mitogen-Activated Protein Kinases/metabolism , Lymphoma, T-Cell/genetics , Lymphoma, T-Cell/metabolism , Lymphoma, T-Cell/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Neoplasm Proteins/genetics , Phosphoproteins/genetics , Phosphoproteins/metabolism , Phosphorylation , Proto-Oncogene Proteins , Survival Analysis , TCF Transcription Factors/genetics , TCF Transcription Factors/metabolism , Transcription Factor AP-1/genetics , Transcription Factor AP-1/metabolism , Transfection , Wnt Proteins/genetics , beta Catenin/genetics , beta Catenin/metabolism
9.
Oncogene ; 24(52): 7656-72, 2005 Nov 21.
Article in English | MEDLINE | ID: mdl-16299527

ABSTRACT

Retroviral insertion mutagenesis screens in mice are powerful tools for efficient identification of oncogenic mutations in an in vivo setting. Many oncogenes identified in these screens have also been shown to play a causal role in the development of human cancers. Sequencing and annotation of the mouse genome, along with recent improvements in insertion site cloning has greatly facilitated identification of oncogenic events in retrovirus-induced tumours. In this review, we discuss the features of retroviral insertion mutagenesis screens, covering the mechanisms by which retroviral insertions mutate cellular genes, the practical aspects of insertion site cloning, the identification and analysis of common insertion sites, and finally we address the potential for use of somatic insertional mutagens in the study of nonhaematopoietic and nonmammary tumour types.


Subject(s)
Mutagenesis, Insertional , Retroviridae/genetics , Cloning, Molecular , DNA Transposable Elements , Genes, Tumor Suppressor , Genetic Testing , Humans , Neoplasms/genetics , Proto-Oncogenes
10.
Article in English | MEDLINE | ID: mdl-16869758

ABSTRACT

Lung tumors are usually classified into small-cell lung cancer (SCLC) or non-SCLC (NSCLC) depending on their pathological and histological characteristics. SCLC is defined not only by its characteristic neuroendocrine differentiation, aggressiveness, and metastatic potential, but also by a specific set of genetic aberrations, including the loss of the tumor suppressor genes p53 and Rb1 and the amplification of any member of the Myc family of oncogenes. We have previously described a mouse model of SCLC by somatic conditional disruption of Trp53 and Rb1 genes that closely resembles the human condition. Based on the possibility to study early tumor lesions and to culture and subclone progressed tumors and metastases, we discuss here a strategy to define genotype-phenotype relationships that can explain the underlying biology of lung neuroendocrine tumors. We have found that tumors may be constituted by genetically variant cell populations, which might represent different progression stages. Interestingly, we observed L-myc amplification and Ascl-1 expression in those populations showing neuroendocrine differentiation. Non-neuroendocrine cell populations from the same tumors did not show L-myc amplification nor Ascl-1 expression. We propose that this genetic divergence can play a relevant role in the definition of some phenotypic characteristics like metastasis potential or chemoresistance.


Subject(s)
Carcinoma, Small Cell/genetics , Lung Neoplasms/genetics , Animals , Carcinoma, Small Cell/pathology , Cell Line, Tumor , Disease Models, Animal , Genes, p53 , Genotype , Humans , Lung Neoplasms/pathology , Mice , Mice, Mutant Strains , Mice, Transgenic , Phenotype , Retinoblastoma Protein/genetics
11.
Nat Genet ; 29(4): 418-25, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11694875

ABSTRACT

Inheritance of one defective BRCA2 allele predisposes humans to breast cancer. To establish a mouse model for BRCA2-associated breast cancer, we generated mouse conditional mutants with BRCA2 and/or p53 inactivated in various epithelial tissues, including mammary-gland epithelium. Although no tumors arose in mice carrying conditional Brca2 alleles, mammary and skin tumors developed frequently in females carrying conditional Brca2 and Trp53 alleles. The presence of one wildtype Brca2 allele resulted in a markedly delayed tumor formation; loss of the wildtype Brca2 allele occurred in a subset of these tumors. Our results show that inactivation of BRCA2 and of p53 combine to mediate mammary tumorigenesis, and indicate that disruption of the p53 pathway is pivotal in BRCA2-associated breast cancer.


Subject(s)
BRCA2 Protein/genetics , Disease Models, Animal , Genes, Tumor Suppressor , Genes, p53 , Mammary Neoplasms, Animal/genetics , Animals , Loss of Heterozygosity , Mice , Mice, Mutant Strains , Mice, Transgenic
13.
Oncogene ; 20(45): 6551-8, 2001 Oct 04.
Article in English | MEDLINE | ID: mdl-11641780

ABSTRACT

The onset of human lung cancer occurs through sequential mutations in oncogenes and tumor suppressor genes. Mutations in K-Ras play a prominent role in human non-small cell lung cancer. We have developed a mouse lung tumor model in which K-Ras can be sporadically activated through Cre-lox mediated somatic recombination. Adenoviral mediated delivery of Cre recombinase in lung epithelial cells gave rise to rapid onset of tumorigenesis, yielding pulmonary adenocarcinomas with 100% incidence after a short latency. The lung tumor lesions shared many features with human non-small cell lung cancer. Our data show that sporadic expression of the K-Ras oncogene is sufficient to elicit lung tumorigenesis. Therefore this model has many advantages over conventional transgenic models used thus far.


Subject(s)
Adenocarcinoma/etiology , Carcinoma, Non-Small-Cell Lung/etiology , Disease Models, Animal , Integrases/genetics , Lung Neoplasms/etiology , Oncogene Protein p21(ras)/genetics , Viral Proteins/genetics , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Adenoviridae/genetics , Alleles , Animals , Carcinoma, Non-Small-Cell Lung/metabolism , Carcinoma, Non-Small-Cell Lung/pathology , Genes, Reporter , Genetic Vectors , Integrases/metabolism , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Mice , Mice, Transgenic , Oncogene Protein p21(ras)/biosynthesis , RNA, Neoplasm/biosynthesis , Recombination, Genetic , Viral Proteins/metabolism
14.
Nature ; 413(6851): 83-6, 2001 Sep 06.
Article in English | MEDLINE | ID: mdl-11544530

ABSTRACT

CDKN2A (INK4a/ARF) is frequently disrupted in various types of human cancer, and germline mutations of this locus can confer susceptibility to melanoma and other tumours. However, because CDKN2A encodes two distinct cell cycle inhibitory proteins, p16INK4a and p14ARF (p19Arf in mice), the mechanism of tumour suppression by CDKN2A has remained controversial. Genetic disruption of Cdkn2a(p19Arf) (hereafter Arf) alone predisposes mice to tumorigenesis, demonstrating that Arf is a tumour-suppressor gene in mice. We mutated mice specifically in Cdkn2a(p16Ink4a) (hereafter Ink4a). Here we demonstrate that these mice, designated Ink4a*/*, do not show a significant predisposition to spontaneous tumour formation within 17 months. Embryo fibroblasts derived from them proliferate normally, are mortal, and are not transformed by oncogenic HRAS. The very mild phenotype of the Ink4a*/* mice implies that the very strong phenotypes of the original Ink4a/ArfDelta2,3 mice were primarily or solely due to loss of Arf. However, Ink4a*/Delta2,3 mice that are deficient for Ink4a and heterozygous for Arf spontaneously develop a wide spectrum of tumours, including melanoma. Treatment of these mice with the carcinogen 7,12-dimethylbenzanthracene (DMBA) results in an increased incidence of melanoma, with frequent metastases. Our results show that, in the mouse, Ink4a is a tumour-suppressor gene that, when lost, can recapitulate the tumour predisposition seen in humans.


Subject(s)
Genes, p16 , Genetic Predisposition to Disease , Melanoma, Experimental/genetics , 9,10-Dimethyl-1,2-benzanthracene , Animals , Carcinogens , Cell Transformation, Neoplastic , Cells, Cultured , Cyclin-Dependent Kinase Inhibitor p16/genetics , Cyclin-Dependent Kinase Inhibitor p16/physiology , Embryo, Mammalian/cytology , Female , Fibroblasts/physiology , Gene Deletion , Genes, ras , Humans , Male , Melanoma, Experimental/pathology , Melanoma, Experimental/secondary , Mice , Point Mutation , Proteins/genetics , Tumor Suppressor Protein p14ARF
15.
Proc Natl Acad Sci U S A ; 98(16): 9209-14, 2001 Jul 31.
Article in English | MEDLINE | ID: mdl-11481484

ABSTRACT

The use of Cre/loxP recombination in mammalian cells has expanded rapidly. We describe here that Cre expression in cultured mammalian cells may result in a markedly reduced proliferation and that this effect is dependent on the endonuclease activity of Cre. Chromosome analysis after Cre expression revealed numerous chromosomal aberrations and an increased number of sister chromatid exchanges. Titration experiments in mouse embryo fibroblasts with a ligand-regulatable Cre-ER(T) show that toxicity is dependent on the level of Cre activity. Prolonged, low levels of Cre activity permit recombination without concomitant toxicity. This urges for a careful titration of Cre activity in conditional gene modification in mammalian cells.


Subject(s)
Cell Division , DNA Damage , Integrases/metabolism , Viral Proteins/metabolism , Aneuploidy , Animals , Cells, Cultured , G2 Phase , Mammals , Mitosis , Recombination, Genetic , Sister Chromatid Exchange
16.
EMBO Rep ; 2(4): 292-7, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11306549

ABSTRACT

Conditional gene inactivation using the Cre/loxP system is widely used, but the difficulty in properly regulating Cre expression remains one of the bottlenecks. One approach to regulate Cre activity utilizes a mutant estrogen hormone-binding domain (ERT) to keep Cre inactive unless the non-steroidal estrogen analog 4-hydroxytamoxifen (OHT) is present. Here we describe a mouse strain expressing Cre-ERT from the ubiquitously expressed ROSA26 (R26) locus. We demonstrate efficient temporal and spatial regulation of Cre recombination in vivo and in primary cells derived from these mice. We show the existence of marked differences in recombination frequencies between different substrates within the same cell. This has important consequences when concurrent switching of multiple alleles within the same cell is needed, and highlights one of the difficulties that may be encountered when using reporter mice as indicator strains.


Subject(s)
Genetic Techniques , Integrases/genetics , Recombination, Genetic , Viral Proteins , Alleles , Animals , Blotting, Southern , Embryo, Mammalian/cytology , Estrogens/metabolism , Genotype , Ligands , Mice , Mice, Knockout , Mice, Transgenic , Models, Genetic , Mutagenesis, Insertional , Mutation , Protein Structure, Tertiary , Stem Cells/metabolism , Time Factors , beta-Galactosidase/metabolism
17.
Development ; 128(9): 1587-97, 2001 May.
Article in English | MEDLINE | ID: mdl-11290297

ABSTRACT

Polycomb group genes were identified as a conserved group of genes whose products are required in multimeric complexes to maintain spatially restricted expression of Hox cluster genes. Unlike in Drosophila, in mammals Polycomb group (PcG) genes are represented as highly related gene pairs, indicative of duplication during metazoan evolution. Mel18 and Bmi1 are mammalian homologs of Drosophila Posterior sex combs. Mice deficient for Mel18 or Bmi1 exhibit similar posterior transformations of the axial skeleton and display severe immune deficiency, suggesting that their gene products act on overlapping pathways/target genes. However unique phenotypes upon loss of either Mel18 or Bmi1 are also observed. We show using embryos doubly deficient for Mel18 and Bmi1 that Mel18 and Bmi1 act in synergy and in a dose-dependent and cell type-specific manner to repress Hox cluster genes and mediate cell survival of embryos during development. In addition, we demonstrate that Mel18 and Bmi1, although essential for maintenance of the appropriate expression domains of Hox cluster genes, are not required for the initial establishment of Hox gene expression. Furthermore, we show an unexpected requirement for Mel18 and Bmi1 gene products to maintain stable expression of Hox cluster genes in regions caudal to the prospective anterior expression boundaries during subsequent development.


Subject(s)
DNA-Binding Proteins/genetics , Genes, Homeobox , Homeodomain Proteins/genetics , Nuclear Proteins/genetics , Proto-Oncogene Proteins/genetics , Repressor Proteins/genetics , Animals , Bone and Bones/embryology , Embryonic and Fetal Development/genetics , Gene Dosage , Gene Expression Regulation, Developmental , Homeodomain Proteins/biosynthesis , Mice , Mice, Mutant Strains , Polycomb Repressive Complex 1 , Polycomb-Group Proteins
18.
Nature ; 410(6832): 1043-4, 2001 Apr 26.
Article in English | MEDLINE | ID: mdl-11323655
19.
Exp Cell Res ; 264(1): 100-10, 2001 Mar 10.
Article in English | MEDLINE | ID: mdl-11237526

ABSTRACT

Much of the advancement in mouse models for cancer during the past 2 decades can be attributed to our increasing capacity to specifically modify the mouse germ line. The first generations of oncomice and tumor-suppressor gene knockouts are now being succeeded by regulatable or conditional mouse tumor models, which can be utilized more effectively to establish correlations between distinct genetic lesions and specific tumor characteristics and to design and improve therapeutic intervention strategies. In this review we try to give the reader a flavor of how the latest reagents can be utilized.


Subject(s)
Disease Models, Animal , Neoplasms/genetics , Animals , Forecasting , Genes, Tumor Suppressor , Genetic Complementation Test , Mice , Mice, Knockout , Neoplasms/therapy , Oncogene Proteins/genetics , Oncogene Proteins/metabolism , Transcriptional Activation
20.
Nucleic Acids Res ; 29(4): E23, 2001 Feb 15.
Article in English | MEDLINE | ID: mdl-11160943

ABSTRACT

A tetracycline-controlled gene expression system provides a powerful tool to dissect the functions of gene products. However, it often appears difficult to establish cell lines or transgenic animals stably expressing tetracycline-dependent transactivators, possibly as a result of toxicity of the transactivator domains used. In order to overcome this problem, we developed a novel tetracycline-dependent transactivator that works efficiently in mammalian cells. This transactivator is a fusion of the tet reverse repressor mutant and the transcriptional activating domain of human E2F4, which is ubiquitously expressed in vivo. We demonstrate here that this tetracycline-regulated gene expression system provides a two log transcriptional activation in mammalian cells as assessed by northern blot and luciferase analyses. Combining this system with green fluorescent protein reporter systems or microarray gene expression profiling will facilitate the study of gene function.


Subject(s)
DNA-Binding Proteins/chemistry , DNA-Binding Proteins/metabolism , Tetracycline/pharmacology , Trans-Activators/metabolism , Transcription Factors/chemistry , Transcription Factors/metabolism , Transcriptional Activation/drug effects , Animals , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cell Line , DNA-Binding Proteins/genetics , Doxycycline/pharmacology , E2F4 Transcription Factor , Escherichia coli , Gene Expression Profiling/methods , Genes, Reporter/genetics , Humans , Kinetics , Mutation/genetics , Protein Structure, Tertiary , RNA, Messenger/genetics , RNA, Messenger/metabolism , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Repressor Proteins/genetics , Repressor Proteins/metabolism , Trans-Activators/chemistry , Trans-Activators/genetics , Transcription Factors/genetics , Transfection , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...